Tesamorelin + Ipamorelin Blend 5mg / 5mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Tesamorelin / Ipamorelin supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF-TESAIPA5/5-B241

Key analytical results include:

• Ipamorelin Assay: 5.35 mg
• Tesamorelin Assay: 5.37 mg
• Identification – Retention Time (Ipamorelin): 0.987
• Identification – Retention Time (Tesamorelin): 0.984
• Bacterial Endotoxins: 0.002 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium. :contentReference[oaicite:0]{index=0}

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

Tesamorelin / Ipamorelin is a dual peptide blend studied in controlled laboratory environments focused on peptide-mediated signalling pathways and receptor interaction systems.

The combination is commonly investigated in biochemical research for its interaction with signalling mechanisms and regulatory peptide systems.

This preparation contains a total of 10 mg of high purity lyophilized peptides supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows precise reconstitution for controlled in vitro experimentation.

Due to its dual peptide composition, this blend is frequently referenced in experimental peptide research models.

Compound Overview

This blend combines Tesamorelin and Ipamorelin, two synthetic peptides studied for their interaction with signalling pathways and regulatory systems.

Within experimental models, the combination is commonly investigated for peptide-mediated signalling dynamics and receptor interaction mechanisms.

Because of its defined multi-peptide profile, the blend is frequently used in laboratory studies examining peptide synergy and signalling processes.

Historical Background and Scientific Context

Scientific interest in peptide combinations has expanded with advances in molecular biology and biochemical research.

Multi-peptide blends have been developed to explore interaction effects between signalling pathways in controlled laboratory environments.

This has enabled deeper investigation into complex peptide-mediated biological mechanisms.

Mechanistic Focus in Research

Within experimental laboratory settings, Tesamorelin / Ipamorelin is commonly studied in relation to peptide-mediated signalling pathways.

Research investigations commonly explore the blend in experimental models examining:

• Peptide signalling pathways
• Receptor interaction dynamics
• Multi-peptide synergy
• Regulatory network interactions
• Intracellular signalling mechanisms
• Comparative peptide research
• Molecular pathway analysis

These experimental models allow scientists to investigate molecular mechanisms involved in peptide-mediated signalling processes.

Research Applications

In controlled research environments, this blend may be utilised in experimental models designed to explore peptide signalling systems and receptor interactions.

Examples of research applications include:

• Peptide signalling pathway investigation
• Receptor interaction research
• Multi-peptide synergy studies
• Comparative peptide research
• Molecular pathway analysis
• Controlled in vitro research
• Laboratory signalling studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Independently analysed by Liquilabs s.r.o. Czechia
• Dual peptide assay verification per compound
• Ipamorelin 5.35 mg and Tesamorelin 5.37 mg confirmed
• Endotoxin level measured at 0.002 EU/mg
• No detectable heavy metals or microbial contamination
• High-purity dual peptide blend for controlled laboratory research
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.